National Health Act 1953 Amendment determination under paragraph 98C(1)(b) conditions (No. PB 34 of 2008) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 34 of 2008
Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.
Dated 3rd March 2008
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — conditions
1 Commencement
This instrument commences on 1 April 2008.
2 Amendment of PB 52 of 2007
Schedule 1 amends PB 52 of 2007.
Schedule 1 Amendments
[1] Schedule 3, for item dealing with Fentanyl
insert as the first entry in the columns in the order indicated:
| Lozenges 200 micrograms (as citrate), 3 |
| Lozenges 400 micrograms (as citrate), 3 |
| Lozenges 600 micrograms (as citrate), 3 |
| Lozenges 800 micrograms (as citrate), 3 |
| Lozenges 1200 micrograms (as citrate), 3 |
| Lozenges 1600 micrograms (as citrate), 3 |
[2] Schedule 3, after item dealing with Methylphenidate, Tablet containing methylphenidate hydrochloride 54 mg (extended release)
insert in the columns in the order indicated:
| Capsule containing methylphenidate hydrochloride 20 mg (modified release) |
| Capsule containing methylphenidate hydrochloride 30 mg (modified release) |
| Capsule containing methylphenidate hydrochloride 40 mg (modified release) |
[3] Schedule 4, item dealing with Oestradiol
omit from the column headed “Form (strength, type, size, etc)”:
Nasal spray containing oestradiol hemihydrate 150 micrograms per actuation, 60 actuations, 4.2 mL
[4] Schedule 4, item dealing with Prochlorperazine
omit from the column headed “Form (strength, type, size, etc)”:
Suppositories containing prochlorperazine equivalent to 5 mg prochlorperazine maleate, 5
0
0
0